 Connection
Larry Allen to Health Expenditures
This is a "connection" page, showing publications Larry Allen has written about Health Expenditures.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.972 |
|
|
|
-
Lowe EF, Gerasta D, Balser M, Page RL, Tsai E, Biermann HD, Mitchell A, Chan D, Matlock DD, Dickert NW, Sloan CE, Allen LA. Contributors and Solutions to High?Out-of-Pocket Costs for Heart?Failure Medications: A State-of-the-Art Review. J Am Coll Cardiol. 2025 Feb 04; 85(4):365-377.
Score: 0.828
-
Dickert NW, Speight CD, Balser M, Biermann H, Davis JK, Halpern SD, Ko YA, Krishnan A, Matlock DD, Mitchell AR, Moore MA, Montembeau SC, Morris AA, Noonan K, Rao BR, Scherer LD, Sloan CE, Ubel PA, Allen LA. Integrating Out-of-Pocket Costs Into Shared Decision-Making for Heart Failure With Reduced Ejection Fraction: A Stepped-Wedge Trial (POCKET-COST-HF). Circ Cardiovasc Qual Outcomes. 2025 Jan; 18(1):e011273.
Score: 0.822
-
Dickert NW, Mitchell AR, Venechuk GE, Matlock DD, Moore MA, Morris AA, Pierce KJ, Speight CD, Allen LA. Show Me the Money: Patients' Perspectives on a Decision Aid for Sacubitril/Valsartan Addressing Out-of-Pocket Cost. Circ Cardiovasc Qual Outcomes. 2020 12; 13(12):e007070.
Score: 0.624
-
Rao BR, Allen LA, Sandhu AT, Dickert NW. Challenges Related to Out-of-Pocket Costs in Heart Failure Management. Circ Heart Fail. 2025 Mar; 18(3):e011584.
Score: 0.209
-
Venechuk GE, Allen LA, Doermann Byrd K, Dickert N, Matlock DD. Conflicting Perspectives on the Value of Neprilysin Inhibition in Heart Failure Revealed During Development of a Decision Aid Focusing on Patient Costs for Sacubitril/Valsartan. Circ Cardiovasc Qual Outcomes. 2020 09; 13(9):e006255.
Score: 0.153
-
Stecker EC, Reisman L, Allen LA, Gluckman TJ. Breaking the Mold: Designing Health Plans That Do Not Impede Delivery of High-Value Care. J Am Coll Cardiol. 2020 06 09; 75(22):2863-2864.
Score: 0.151
-
Smith GH, Shore S, Allen LA, Markham DW, Mitchell AR, Moore M, Morris AA, Speight CD, Dickert NW. Discussing Out-of-Pocket Costs With Patients: Shared Decision Making for Sacubitril-Valsartan in Heart Failure. J Am Heart Assoc. 2019 01 08; 8(1):e010635.
Score: 0.137
-
Montembeau SC, Rao BR, Mitchell AR, Speight CD, Allen LA, Halpern SD, Ko YA, Matlock DD, Moore MA, Morris AA, Scherer LD, Ubel P, Dickert NW. Integrating Cost into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction (POCKET-COST-HF): A Trial Providing Out-of-Pocket Costs for Heart Failure Medications during Clinical Encounters. Am Heart J. 2024 03; 269:84-93.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|